Recent Posts
- Phase 3 Aspire trial of gene therapy GTX-102 doses 1st patient
- FAST’s Global Science Summit reminded us of the power of hope
- GTX-102 may help cognition in Angelman syndrome children, teens
- Burdine, Angelman researcher and parent, recognized for work
- Processing the complexities of our son’s happy demeanor
- Reflections after a year of early intervention therapy
- Children’s Colorado clinic named Angelman center of excellence
- Overcoming fear after an Angelman syndrome diagnosis
- Anxiety, repetitive behaviors predict sleep problems in Angelman
- Angelman syndrome treatment ION582 eases symptoms: Trial data